Multitrace-4 Pediatric Interactions
There are 198 drugs known to interact with Multitrace-4 Pediatric (trace elements), along with 4 disease interactions. Of the total drug interactions, 5 are major, 84 are moderate, and 109 are minor.
- View all 198 medications that may interact with Multitrace-4 Pediatric
- View Multitrace-4 Pediatric disease interactions (4)
Most frequently checked interactions
View interaction reports for Multitrace-4 Pediatric (trace elements) and the medicines listed below.
- Adcetris (brentuximab)
- Adriamycin (doxorubicin)
- Advate (antihemophilic factor)
- amoxicillin / clarithromycin / omeprazole
- Bivigam (immune globulin intravenous)
- Braftovi (encorafenib)
- Brethine (terbutaline)
- Brevibloc (esmolol)
- conivaptan
- Cytoxan (cyclophosphamide)
- Diacomit (stiripentol)
- Emgality (galcanezumab)
- enalapril
- Etopophos (etoposide)
- Givlaari (givosiran)
- Infuvite Pediatric (multivitamin)
- Ingrezza (valbenazine)
- Juluca (dolutegravir / rilpivirine)
- Lanoxin (digoxin)
- loracarbef
- Lortab (acetaminophen / hydrocodone)
- Mektovi (binimetinib)
- Mepron (atovaquone)
- Meticorten (prednisone)
- moxifloxacin
- Oncovin (vincristine)
- Perikabiven (parenteral nutrition solution w/electrolytes)
- Poteligeo (mogamulizumab)
- Rexulti (brexpiprazole)
- Rituxan (rituximab)
Multitrace-4 Pediatric disease interactions
There are 4 disease interactions with Multitrace-4 Pediatric (trace elements) which include:
Report options
QR code containing a link to this page
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.